Technology
Health
Pharmaceutical
Ovid Therapeutics
$2.309876543210-$,.9876543210-$,.9876543210-$,.9876543210-$,.9876543210-$,.9876543210-$,.
$2.30
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
-$0.05 (-2.13%) As of 12:19 PM EDT today
-$0.05 (-2.13%) Today
Why Robinhood?
You can buy or sell OVID and other stocks, options, ETFs, and crypto commission-free!
About OVID
Ovid Therapeutics, Inc. focuses on developing medicines for patients and families living with rare neurological disorders. The company was founded by Matthew During in April 2014 and is headquartered in New York, NY.
Employees
55
Headquarters
New York, New York
Founded
2014
Market Cap
90.93M
Price-Earnings Ratio
—
Dividend Yield
0.00
Average Volume
274.75K
High Today
$2.38
Low Today
$2.28
Open Price
$2.37
Volume
65.36K
52 Week High
$11.02
52 Week Low
$1.53
Collections
Technology
Health
Pharmaceutical
Therapy
2017 IPO
US
North America
Price Paid on Robinhood
2% Lower
Right Now
52 Week Low
$1.53
Average Price Paid
$2.36
52 Week High
$11.02
Analyst Ratings
100%
of 7 ratings
Buy
100%
Hold
0%
Sell
0%
OVID Earnings
-$0.59
-$0.53
-$0.48
-$0.42
Q4 2017
Q1 2018
Q2 2018
Q3 2018
Q4 2018
Q1 2019
Q2 2019
Estimated
—
Actual
Expected Aug 8, Pre-Market